scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033264879 |
P356 | DOI | 10.1186/S40709-015-0035-2 |
P932 | PMC publication ID | 4619013 |
P698 | PubMed publication ID | 26500892 |
P5875 | ResearchGate publication ID | 283260574 |
P2093 | author name string | Ying Fang | |
Yan Fu | |||
Changyan Xu | |||
P2860 | cites work | PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha | Q24337070 |
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition | Q24646324 | ||
The basics of epithelial-mesenchymal transition | Q24652992 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA | Q24672429 | ||
Epithelial-mesenchymal plasticity in carcinoma metastasis | Q26859804 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer | Q28385520 | ||
MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer | Q33590704 | ||
Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets | Q33711948 | ||
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples | Q33891538 | ||
MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1 | Q33999853 | ||
Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma | Q34441361 | ||
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer | Q34985302 | ||
Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro | Q35010133 | ||
Clinically relevant microRNAs in ovarian cancer | Q35204609 | ||
Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer | Q35919161 | ||
MicroRNA expression and function in cancer | Q36637333 | ||
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition | Q37059954 | ||
Regulation of microRNAs by epigenetics and their interplay involved in cancer | Q37418150 | ||
Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience | Q38161377 | ||
MicroRNAs as prognostic markers in ovarian cancer. | Q38205688 | ||
Oncogenes associated with drug resistance in ovarian cancer | Q38226577 | ||
MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines | Q38922911 | ||
Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer | Q40949515 | ||
Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers. | Q42255764 | ||
Ovarian cancer: a molecularly insidious disease | Q43114620 | ||
[Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro]. | Q50467951 | ||
Clinical application of HE4 and CA125 in ovarian cancer type I and type II detection and differential diagnosis. | Q53570674 | ||
Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Q53629574 | ||
Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer. | Q54264657 | ||
Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients. | Q54623612 | ||
P921 | main subject | microRNA | Q310899 |
ovarian carcinoma | Q18556145 | ||
P304 | page(s) | 12 | |
P577 | publication date | 2015-10-22 | |
P1433 | published in | Journal of biological research (Thessalonike, Greece) | Q26842888 |
P1476 | title | MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling | |
P478 | volume | 22 |
Q36070798 | Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma |
Q91596428 | Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer? |
Q90451191 | Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p |
Q48041255 | Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. |
Q57476011 | LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN |
Q30244282 | MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications |
Q49478023 | MicroRNA-17-5p contributes to osteoarthritis progression by binding p62/SQSTM1. |
Q37298302 | MicroRNA-17-5p promotes gastric cancer proliferation, migration and invasion by directly targeting early growth response 2 |
Q51334810 | MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma. |
Q39382756 | MicroRNA-mediated drug resistance in ovarian cancer |
Q39333266 | MicroRNAs in gynecological cancers: Small molecules with big implications |
Q26773316 | Oncogenic MicroRNAs: Key Players in Malignant Transformation |
Q47193672 | Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis |
Q58759827 | Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer |
Q92636165 | Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview |
Q42658274 | The Different Mechanisms of Cancer Drug Resistance: A Brief Review. |
Q37626754 | miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer |
Q92748185 | miRNA profile in ovarian cancer |
Q92617023 | miRNA-17 promotes nasopharyngeal carcinoma radioresistance by targeting PTEN/AKT |
Q58799032 | miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer |
Search more.